Hotline:
+ 49 (0) 2204 2918806

Estudios en la categoría Cuidado de la Salud

Artículo 1 hasta 10 de 225

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 23
  1. Precio neto*
    Año
  2. US$ 2.836,38
    2013
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: HIV - Current and Future Players

    GlobalData
    71 Páginas
    Introduction GlobalData has released its pharma report, “PharmaPoint: HIV - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing HIV Market. The report identifies and analyses the key companies shaping and driving the global HIV market. The r
    Englisch | Report | Código: 330440
  3. US$ 1.889,34
    2014
    Für diese Studie liegt keine Bewertung vor.

    CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia

    GlobalData
    246 Páginas
    GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia". The report is an essential source of information and analysis regarding the healthcare, regulatory and reimbursement landscape in Saudi Arabia. It identifies key trends in the hea
    Englisch | Zukunftsanalyse | Código: 403479
  4. US$ 2.367,60
    2013
    Für diese Studie liegt keine Bewertung vor.

    Friedreich Ataxia Global Clinical Trials Review, H1, 2013

    GlobalData
    87 Páginas
    Introduction GlobalData's clinical trial report, “Friedreich Ataxia Global Clinical Trials Review, H1, 2013" provides data on the Friedreich Ataxia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Friedreich Ataxia. It includes an overview of the trial numbers and their recr
    Englisch | Report | Código: 330104
  5. US$ 2.367,60
    2013
    Für diese Studie liegt keine Bewertung vor.

    Gastrointestinal Hemorrhage Global Clinical Trials Review, H1, 2013

    GlobalData
    82 Páginas
    Introduction GlobalData's clinical trial report, “Gastrointestinal Hemorrhage Global Clinical Trials Review, H1, 2013" provides data on the Gastrointestinal Hemorrhage clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gastrointestinal Hemorrhage. It includes an overview of th
    Englisch | Report | Código: 330308
  6. US$ 468,78
    2013
    Für diese Studie liegt keine Bewertung vor.

    ICT Spend Predictions in Medium-sized Dutch Healthcare Providers - Estimated ICT budget breakdowns in 2013

    Kable Global ICT Intelligence
    19 Páginas
    SynopsisThis report illustrates how Kable expects Medium-sized Dutch Healthcare Providers to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, telecommunications and consulting.SummaryWhy was the report written?This report presents the output from Kable's ICT spend prediction
    Englisch | Databook | Código: 330837
  7. US$ 947,04
    2012
    Für diese Studie liegt keine Bewertung vor.

    Partnerships, Licensing, Investments and M&A Deals and Trends For November 2012 In Pharmaceuticals

    GlobalData
    69 Páginas
    Introduction GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends For November 2012 In Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on
    Englisch | Report | Código: 329298
  8. US$ 4.730,46
    2013
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: HIV - Brazil Drug Forecast and Market Analysis to 2022

    GlobalData
    144 Páginas
    Introduction GlobalData has released its new Country report, “PharmaPoint: HIV - Brazil Drug Forecast and Market Analysis to 2022”. Human Immunodeficiency Virus (HIV), the causative agent of AIDS, has claimed millions of lives since its emergence. However, the advent of antiretroviral therapy (ART) has transformed the face of HIV/AIDS
    Englisch | Report | Código: 330276
  9. US$ 4.730,46
    2013
    Für diese Studie liegt keine Bewertung vor.

    PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022

    GlobalData
    130 Páginas
    Introduction GlobalData has released its new Country report, “PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022”. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction. Th
    Englisch | Report | Código: 330281
  10. US$ 6.624,54
    2013
    Für diese Studie liegt keine Bewertung vor.

    Vimpat (Epilepsy) - Forecast and Market Analysis to 2022

    GlobalData
    51 Páginas
    Introduction GlobalData has released its new PharmaPoint Drug Evaluation report, “Vimpat (Epilepsy) - Forecast and Market Analysis to 2022”. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction
    Englisch | Report | Código: 330445
  11. US$ 4.214,33
    2014
    Für diese Studie liegt keine Bewertung vor.

    MediPoint: Companion Diagnostic Tests in Oncology - US Analysis and Market Forecasts

    GlobalData
    423 Páginas
    A companion diagnostic test is defined as an in vitro diagnostic device or an imaging tool whose use allows the safe application of a therapy. In-vitro Companion Diagnostic tests measure the expression or presence of a specific biomarker that is linked to a disease condition or therapy. This report provides an analysis of the companion di
    Englisch | Zukunftsanalyse | Código: 403063

Artículo 1 hasta 10 de 225

  1. 1
  2. | 2
  3. | 3
  4. | 4
  5. | 5
  6. | 6
  7. | 7
  8. | 8
  9. | 9
  10. | 10
  11. ...
  12. | 23